Skip to main content
An official website of the United States government

Supportive Care and Symptom Management

The Supportive Care and Symptom Management program supports studies on the prevention or treatment of acute and chronic symptoms and morbidities related to cancer and its treatment. This includes the impact on the quality of life of patients and their informal caregivers. The program also supports studies of patients and their caregivers at the end of life.

On This Page

  • All Heading 2s will automatically be pulled in to this list.
  • Do not edit the content on this template.

About Supportive Care and Symptom Management

The program supports research in three areas: prevention or treatment of acute or chronic symptoms and morbidities related to cancer, its treatment and caregiving (symptom management research); effects on quality of life from cancer, its treatment and caregiving (quality of life research); and end-of-life psychosocial issues, caregiving and treatment strategies (end-of-life research).

Through the NCI Community Oncology Research Program (NCORP), clinical trials are underway to evaluate therapies to prevent or ameliorate a broad range of symptoms and/or toxicities associated with cancer its treatment and caregiving. Other studies funded separately are investigating a range of treatment effects on health-related quality of life and a variety of influences on the end-of-life cancer experience. 

Topic Areas include: Anorexia, Cachexia, Cardiotoxicity, Caregiver Issues, Cognitive Dysfunction, Distress/Anxiety/Depression, End of Life, Fatigue, Geriatrics, Hot Flashes, Lymphedema, Medication Adherence, Mucositis, Multiple Symptoms, Musculoskeletal Symptoms, Nausea, Neuropathy, Nutrition, Oral Complications, Other Supportive Care Issues, Pain, Palliative Care, Pediatrics/Adolescents/Young Adult, Physical Functioning, Quality of Life, Skin Toxicities, Sleep Disorders, and Urinary Complications.

Selected Topics

Funding Opportunities

No matching Funding Opportunities were found.

View All Funding Opportunities

Grantee Details

PI Name Sort descending PI Organization Title Grant Number Program Official
Infante, Rodney E

Ut Southwestern Medical Center
United States

Identifying the Cellular and Molecular Targets of JAK/STAT-Driven Adipose Wasting to Reverse Cancer Cachexia 3R01CA266900-04S1 Marjorie Perloff, M.D.
Infante, Rodney E

Ut Southwestern Medical Center
United States

Identifying the Cellular and Molecular Targets of JAK/STAT-Driven Adipose Wasting to Reverse Cancer Cachexia 3R01CA266900-04S1 Marjorie Perloff, M.D.
Infante, Rodney E

Ut Southwestern Medical Center
United States

Identifying the Cellular and Molecular Targets of JAK/STAT-Driven Adipose Wasting to Reverse Cancer Cachexia 3R01CA266900-04S1 Marjorie Perloff, M.D.
Irvin, William J

Southeast Clinical Oncol Res Consortium
United States

NCI Community Oncology Research Program 2025 Extension Request 3UG1CA189858-11S1 Vanessa A. White, M.P.H.
Irvin, William J

Southeast Clinical Oncol Res Consortium
United States

NCI Community Oncology Research Program 2025 Extension Request 3UG1CA189858-11S1 Vanessa A. White, M.P.H.
Iwelunmor, Juliet

Washington University
United States

Innovative Rapid Enabling, Affordable, point-of-Care HPV Self-Testing Strategy (I-REACH) 3U01CA279863-04S1 Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Iyer, Prasad G.

Mayo Clinic Arizona
United States

Minimally Invasive Molecular Approaches for the Detection of Barrett’s Esophagus and Esophageal Adenocarcinoma 2R01CA241164-07 Matthew Young, Ph.D.
Jacob, Jennifer B

Henry Ford Health + Michigan State University Health Sciences
United States

Defining Cancer Intervention Targets by Functional Genomics Analysis of Outbred F1 Mice 5R01CA278818-03
James, Aimee S

Washington University
United States

Administrative Supplement to Building equity in cancer screening through research: The Siteman Catchment CSRN Hub 3UG1CA286946-02S1 Elyse LeeVan, M.D., M.P.H.
Jang, Mi-Hyeon

Rutgers Biomedical And Health Sciences
United States

Identification of novel biomarkers and therapeutic strategies in chemobrain. 5R01CA293210-02 John Clifford, Ph.D.
Jang, Mi-Hyeon

Rutgers Biomedical And Health Sciences
United States

Identification of novel biomarkers and therapeutic strategies in chemobrain. 5R01CA293210-02 John Clifford, Ph.D.
Jaslowski, Anthony J

St. Vincent Hospital
United States

Cancer Research of Wisconsin and Northern Michigan (CROWN) Consortium 3UG1CA239769-06S1 Vanessa A. White, M.P.H.
Jaslowski, Anthony J

St. Vincent Hospital
United States

Cancer Research of Wisconsin and Northern Michigan (CROWN) Consortium 3UG1CA239769-06S1 Vanessa A. White, M.P.H.
Ji, Hanlee P

Stanford University
United States

Precision Interception of Gastric Cancer Precursors Through Molecular and Cellular Risk Stratification 5P01CA265772-03 Asad Umar, D.V.M., Ph.D.
Ji, Hanlee P

Stanford University
United States

Single-molecule nanopore-based identification of methylome signatures in cfDNA for early colorectal cancer detection 5U01CA282212-02 Claire Zhu, Ph.D.

Clinical Trials

Status

No matching Clinical Trials were found.

View All Clinical Trials